BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9678798)

  • 1. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients.
    Hammarström V; Pauksen K; Björkstrand B; Simonsson B; Oberg G; Ljungman P
    Bone Marrow Transplant; 1998 Jul; 22(1):67-71. PubMed ID: 9678798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
    Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
    Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
    Prager J; Baumert A; Thilo W; Hermann J; Fuchs D; Sauerbrey A; Zintl F
    Kinderarztl Prax; 1992 Nov; 60(8):230-8. PubMed ID: 1469826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation.
    Pauksen K; Linde A; Ljungman P; Bolme P; Lönnerholm G; Oberg G; Sjölin J
    Bone Marrow Transplant; 1995 Dec; 16(6):807-13. PubMed ID: 8750274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
    Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
    Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
    Ljungman P; Wiklund-Hammarsten M; Duraj V; Hammarström L; Lönnqvist B; Paulin T; Ringdén O; Pepe MS; Gahrton G
    J Infect Dis; 1990 Aug; 162(2):496-500. PubMed ID: 2197342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivation of hepatitis B virus after autologous peripheral blood stem cell transplantation in patients with positive hepatitis B surface antibodies].
    Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T
    Rinsho Ketsueki; 2000 Apr; 41(4):322-8. PubMed ID: 10846463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reimmunization after blood or marrow stem cell transplantation.
    Singhal S; Mehta J
    Bone Marrow Transplant; 1999 Apr; 23(7):637-46. PubMed ID: 10218839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
    Parkkali T; Olander RM; Ruutu T; Vuontela K; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1997 May; 19(9):933-8. PubMed ID: 9156269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants.
    Henon PR; Liang H; Beck-Wirth G; Eisenmann JC; Lepers M; Wunder E; Kandel G
    Bone Marrow Transplant; 1992 Apr; 9(4):285-91. PubMed ID: 1376185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study of rhG-CSF in accelerating hematological recovery following autologous hematopoietic stem cells transplantation].
    Yang JL; Shi YK; He XH; Zhou SY; Zhou AP; Han XH; Liu P; Zhang CG; Ai B
    Ai Zheng; 2003 Aug; 22(8):785-9. PubMed ID: 12917020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Total body irradiation etoposide followed by autologous hematopoietic stem cell transplantion for non-Hodgkin's lymphoma].
    Shi Y; Lei Y; Zhou S
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):658-61. PubMed ID: 11038787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
    Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
    Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
    Nieboer P; de Vries EG; Mulder NH; Sleijfer DT; Willemse PH; Hospers GA; Gietema JA; Sluiter WJ; van Der Graaf WT
    Bone Marrow Transplant; 2001 May; 27(9):959-66. PubMed ID: 11436106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.